Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 360Neoplasms 254Prostatic Neoplasms 206Colorectal Neoplasms 157Lung Neoplasms 136Carcinoma, Non-Small-Cell Lung 112Leukemia, Myeloid, Acute 109Pancreatic Neoplasms 99Multiple Myeloma 93Glioblastoma 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Brain Neoplasms 78Head and Neck Neoplasms 77Carcinoma, Hepatocellular 70Melanoma 68Squamous Cell Carcinoma of Head and Neck 66Uterine Cervical Neoplasms 61Ovarian Neoplasms 61Neoplasm Metastasis 59Rectal Neoplasms 53Hematologic Neoplasms 53Glioma 53Stomach Neoplasms 50Recurrence 49Carcinoma, Renal Cell 49Myelodysplastic Syndromes 47Sarcoma 46Motor Activity 46Triple Negative Breast Neoplasms 44Esophageal Neoplasms 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Cytomegalovirus Infections × 30 days × Clear all
NCT04364178 2026-05-27

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Stanford University

Phase 1/2 Terminated
8 enrolled 14 charts

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT02506933 2026-05-11

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

City of Hope Medical Center

Phase 2 Active not recruiting
102 enrolled 10 charts
LymphoidMyeloidOther hematologic neoplasm

Lymphadenopathy, Cytomegalovirus Infections, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡